U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07430748) titled 'REGENFAST vs L-PRF in Periodontal Regeneration' on Feb. 18.
Brief Summary: Introduction: Periodontal disease causes the progressive loss of supporting structures of the teeth, resulting in bone and soft tissue defects that compromise function and aesthetics. Regenerative periodontal therapy aims to restore these tissues through techniques that stimulate bone and connective tissue regeneration. Among the biomaterials used, Leukocyte- and Platelet-Rich Fibrin (L-PRF) has become widely applied due to its autologous origin, simplicity of preparation, and capacity to release growth factors that promote angiogenesis and wound healing. How...